Anar al contingut
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Tots els camps
Títol
Autor
Matèria
Signatura
ISBN/ISSN
Etiqueta
Trobar
Avançada
Safety and efficacy of liraglu...
Citar
Enviar aquest missatge de text
Enviar per correu electrònic aquest
Imprimir
Exportar registre
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enllaç permanent
Safety and efficacy of liraglutide in patients with type 2 diabetes with elevated liver enzymes: individual patient data meta-analysis of the LEAD programme
Dades bibliogràfiques
Autors principals:
Armstrong, M
,
Houlihan, D
,
Rowe, I
,
Clausen, W
,
Elbrond, B
,
Gough, S
,
Tomlinson, J
,
Newsome, P
Format:
Conference item
Publicat:
2013
Fons
Descripció
Ítems similars
Visualització del personal
Ítems similars
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.
per: Armstrong, M, et al.
Publicat: (2013)
Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: Individual patient data meta-analysis of the LEAD program
per: Armstrong, M, et al.
Publicat: (2013)
High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program
per: Armstrong, M, et al.
Publicat: (2010)
EFFECTS OF TWO YEARS OF LIRAGLUTIDE TREATMENT ON FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: ANALYSIS OF THE LEAD-2 EXTENSION TRIAL
per: Armstrong, M, et al.
Publicat: (2010)
High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program
per: Armstrong, M, et al.
Publicat: (2010)